Devices and therapies that treat chronic diseases and medical apps for smartphones are among medical innovations that will profoundly affect healthcare in 2012, according to a list compiled by physicians and scientists at the Cleveland Clinic.
Panelists evaluate nominated innovations for four criteria, including:
- Significant potential for short-term clinical impact.
- A high probability of success.
- Devices and therapies that are already on the market or close to being introduced.
- Those with sufficient data available to support the nomination.
The procedure takes 40 minutes and targets the renal sympathetic system, which has small nerves that carry signals between the brain and the kidneys. When these nerves are disrupted, blood-pressure levels improve.
Ardian, the Mountain View, Calif.-based company that developed catheter-based renal denervation, was acquired by Medtronic in November 2010 for $800 million, plus commercial milestones. Although the Food and Drug Administration hasn't approved the catheter system, it has received the CE marking (CE stands for European conformity, in French) to be sold in Europe and is listed by Australia's regulatory agency for drugs and devices, the Therapeutic Goods Administration.